Fingerprint
Dive into the research topics of 'Phase III double-blind, placebo-controlled study of gabapentin for the prevention of delayed chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy, NCCTG N08C3 (Alliance)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically